APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Injectable Hyaluronic Acid and Botulinum Toxin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Injectable Hyaluronic Acid and Botulinum Toxin Industry Growth and Trends Forecast to 2032

20 December 2025126 pages

Choose your research edition.

Industry ResearchInjectable Hyaluronic Acid and Botulinum Toxin Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable Hyaluronic Acid and Botulinum Toxin Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Injectable Hyaluronic Acid and Botulinum Toxin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable Hyaluronic Acid and Botulinum Toxin Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable Hyaluronic Acid and Botulinum Toxin Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Injectable Hyaluronic Acid and Botulinum Toxin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Injectable Hyaluronic Acid and Botulinum Toxin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Injectable Hyaluronic Acid and Botulinum Toxin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injectable Hyaluronic Acid and Botulinum Toxin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Injectable Hyaluronic Acid and Botulinum Toxin include Haohai Biological, AbbVie, US World Meds, Teoxane, Suneva Medical, Sinclair, SciVision Biotech, Prollenium and Merz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Injectable Hyaluronic Acid and Botulinum Toxin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Injectable Hyaluronic Acid and Botulinum Toxin market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Injectable Hyaluronic Acid and Botulinum Toxin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Injectable Hyaluronic Acid and Botulinum Toxin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Injectable Hyaluronic Acid and Botulinum Toxin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Injectable Hyaluronic Acid and Botulinum Toxin Market by Company

Haohai Biological

AbbVie

US World Meds

Teoxane

Suneva Medical

Sinclair

SciVision Biotech

Prollenium

Merz

Medytox

LIBP

LG Life Sciences

JETEMA

Ipsen

Hugel

Galderma

Elravie (Humedix)

Daewoong

Croma-Pharma

Cleviel (Pharma Research Products)

CG Bio

Caregen

Bohus BioTech

Bloomage Bio

Beijing IMEIK

Injectable Hyaluronic Acid and Botulinum Toxin Segment by Type

Injectable Hyaluronic Acid

Botulinum Toxin

Injectable Hyaluronic Acid and Botulinum Toxin Segment by Application

Cosmetic

Medical

Injectable Hyaluronic Acid and Botulinum Toxin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Hyaluronic Acid and Botulinum Toxin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Hyaluronic Acid and Botulinum Toxin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Hyaluronic Acid and Botulinum Toxin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Injectable Hyaluronic Acid and Botulinum Toxin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Injectable Hyaluronic Acid and Botulinum Toxin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injectable Hyaluronic Acid Table 2. Major Company of Botulinum Toxin Table 3. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 5. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Type (2021-2026) Table 8. Global Injectable Hyaluronic Acid and Botulinum Toxin Price by Type (2021-2026) & (US$/unit) Table 9. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2027-2032) & (k units) Table 10. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Type (2027-2032) Table 13. Global Injectable Hyaluronic Acid and Botulinum Toxin Price by Type (2027-2032) & (US$/unit) Table 14. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 15. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 17. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 21. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Type (2021-2026) & (US$ Million) Table 24. Injectable Hyaluronic Acid and Botulinum Toxin Industry Trends Table 25. Injectable Hyaluronic Acid and Botulinum Toxin Industry Drivers Table 26. Injectable Hyaluronic Acid and Botulinum Toxin Industry Opportunities and Challenges Table 27. Injectable Hyaluronic Acid and Botulinum Toxin Industry Restraints Table 28. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Injectable Hyaluronic Acid and Botulinum Toxin Revenue Market Share by Company (2021-2026) Table 30. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Company (2021-2026) & (k units) Table 31. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Share by Company (2021-2026) Table 32. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Injectable Hyaluronic Acid and Botulinum Toxin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Injectable Hyaluronic Acid and Botulinum Toxin Major Company Production Sites and Headquarters Table 35. Global Injectable Hyaluronic Acid and Botulinum Toxin Company, Product Type & Application Table 36. Global Injectable Hyaluronic Acid and Botulinum Toxin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Injectable Hyaluronic Acid and Botulinum Toxin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2021-2026) & (k units) Table 41. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Region (2021-2026) Table 44. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2027-2032) & (k units) Table 46. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Region (2027-2032) Table 49. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 52. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Application (2021-2026) Table 55. Global Injectable Hyaluronic Acid and Botulinum Toxin Price by Application (2021-2026) & (US$/unit) Table 56. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2027-2032) & (k units) Table 57. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Application (2027-2032) Table 60. Global Injectable Hyaluronic Acid and Botulinum Toxin Price by Application (2027-2032) & (US$/unit) Table 61. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 62. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 64. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 68. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Application (2021-2026) & (US$ Million) Table 71. Haohai Biological Company Information Table 72. Haohai Biological Business Overview Table 73. Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 75. Haohai Biological Recent Development Table 76. AbbVie Company Information Table 77. AbbVie Business Overview Table 78. AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 80. AbbVie Recent Development Table 81. US World Meds Company Information Table 82. US World Meds Business Overview Table 83. US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 85. US World Meds Recent Development Table 86. Teoxane Company Information Table 87. Teoxane Business Overview Table 88. Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 90. Teoxane Recent Development Table 91. Suneva Medical Company Information Table 92. Suneva Medical Business Overview Table 93. Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 95. Suneva Medical Recent Development Table 96. Sinclair Company Information Table 97. Sinclair Business Overview Table 98. Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 100. Sinclair Recent Development Table 101. SciVision Biotech Company Information Table 102. SciVision Biotech Business Overview Table 103. SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 105. SciVision Biotech Recent Development Table 106. Prollenium Company Information Table 107. Prollenium Business Overview Table 108. Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 110. Prollenium Recent Development Table 111. Merz Company Information Table 112. Merz Business Overview Table 113. Merz Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Merz Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 115. Merz Recent Development Table 116. Medytox Company Information Table 117. Medytox Business Overview Table 118. Medytox Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Medytox Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 120. Medytox Recent Development Table 121. LIBP Company Information Table 122. LIBP Business Overview Table 123. LIBP Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. LIBP Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 125. LIBP Recent Development Table 126. LG Life Sciences Company Information Table 127. LG Life Sciences Business Overview Table 128. LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 130. LG Life Sciences Recent Development Table 131. JETEMA Company Information Table 132. JETEMA Business Overview Table 133. JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 135. JETEMA Recent Development Table 136. Ipsen Company Information Table 137. Ipsen Business Overview Table 138. Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 140. Ipsen Recent Development Table 141. Hugel Company Information Table 142. Hugel Business Overview Table 143. Hugel Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Hugel Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 145. Hugel Recent Development Table 146. Galderma Company Information Table 147. Galderma Business Overview Table 148. Galderma Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Galderma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 150. Galderma Recent Development Table 151. Elravie (Humedix) Company Information Table 152. Elravie (Humedix) Business Overview Table 153. Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 155. Elravie (Humedix) Recent Development Table 156. Daewoong Company Information Table 157. Daewoong Business Overview Table 158. Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 159. Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 160. Daewoong Recent Development Table 161. Croma-Pharma Company Information Table 162. Croma-Pharma Business Overview Table 163. Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 164. Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 165. Croma-Pharma Recent Development Table 166. Cleviel (Pharma Research Products) Company Information Table 167. Cleviel (Pharma Research Products) Business Overview Table 168. Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 169. Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 170. Cleviel (Pharma Research Products) Recent Development Table 171. CG Bio Company Information Table 172. CG Bio Business Overview Table 173. CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 174. CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 175. CG Bio Recent Development Table 176. Caregen Company Information Table 177. Caregen Business Overview Table 178. Caregen Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 179. Caregen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 180. Caregen Recent Development Table 181. Bohus BioTech Company Information Table 182. Bohus BioTech Business Overview Table 183. Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 184. Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 185. Bohus BioTech Recent Development Table 186. Bloomage Bio Company Information Table 187. Bloomage Bio Business Overview Table 188. Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 189. Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 190. Bloomage Bio Recent Development Table 191. Beijing IMEIK Company Information Table 192. Beijing IMEIK Business Overview Table 193. Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 194. Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio Table 195. Beijing IMEIK Recent Development Table 196. North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 197. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 198. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2021-2026) Table 199. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecast by Country (2027-2032) & (k units) Table 200. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share Forecast by Country (2027-2032) Table 201. North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country (2021-2026) & (US$ Million) Table 203. North America Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Country (2021-2026) Table 204. North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. North America Injectable Hyaluronic Acid and Botulinum Toxin Market Share Forecast by Country (2027-2032) Table 206. Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 207. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 208. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2021-2026) Table 209. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecast by Country (2027-2032) & (k units) Table 210. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share Forecast by Country (2027-2032) Table 211. Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country (2021-2026) & (US$ Million) Table 213. Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Country (2021-2026) Table 214. Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Share Forecast by Country (2027-2032) Table 216. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 217. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 218. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2021-2026) Table 219. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecast by Country (2027-2032) & (k units) Table 220. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share Forecast by Country (2027-2032) Table 221. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country (2021-2026) & (US$ Million) Table 223. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Country (2021-2026) Table 224. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Share Forecast by Country (2027-2032) Table 226. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 227. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 228. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2021-2026) Table 229. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecast by Country (2027-2032) & (k units) Table 230. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share Forecast by Country (2027-2032) Table 231. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 232. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country (2021-2026) & (US$ Million) Table 233. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Country (2021-2026) Table 234. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 235. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Market Share Forecast by Country (2027-2032) Table 236. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 237. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026) & (k units) Table 238. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share by Country (2021-2026) Table 239. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecast by Country (2027-2032) & (k units) Table 240. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share Forecast by Country (2027-2032) Table 241. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 242. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country (2021-2026) & (US$ Million) Table 243. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Country (2021-2026) Table 244. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 245. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Share Forecast by Country (2027-2032) Table 246. Key Raw Materials Table 247. Raw Materials Key Suppliers Table 248. Injectable Hyaluronic Acid and Botulinum Toxin Distributors List Table 249. Injectable Hyaluronic Acid and Botulinum Toxin Customers List Table 250. Research Programs/Design for This Report Table 251. Authors List of This Report Table 252. Secondary Sources Table 253. Primary Sources List of Figures Figure 1. Injectable Hyaluronic Acid and Botulinum Toxin Image Figure 2. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size (2021-2032) & (US$ Million) Figure 4. Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (2021-2032) & (k units) Figure 5. Injectable Hyaluronic Acid Image Figure 6. Global Injectable Hyaluronic Acid Sales YoY Growth (2021-2032) & (k units) Figure 7. Botulinum Toxin Image Figure 8. Global Botulinum Toxin Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Type 2025 VS 2032 Figure 11. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Type in 2025 Figure 12. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Type in 2025 Figure 13. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Injectable Hyaluronic Acid and Botulinum Toxin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cosmetic Image Figure 24. Global Cosmetic Sales YoY Growth (2021-2032) & (k units) Figure 25. Medical Image Figure 26. Global Medical Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Application 2025 VS 2032 Figure 29. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Application in 2025 Figure 30. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Application in 2025 Figure 31. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Application in 2025 Figure 32. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Application in 2025 Figure 35. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Market Share in Value by Application in 2025 Figure 39. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Injectable Hyaluronic Acid and Botulinum Toxin Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Injectable Hyaluronic Acid and Botulinum Toxin Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Hyaluronic Acid
  • Botulinum Toxin
Applications
  • Cosmetic
  • Medical
Companies covered
  • Haohai Biological
  • AbbVie
  • US World Meds
  • Teoxane
  • Suneva Medical
  • Sinclair
  • SciVision Biotech
  • Prollenium
  • Merz
  • Medytox
  • LIBP
  • LG Life Sciences
  • JETEMA
  • Ipsen
  • Hugel
  • Galderma
  • Elravie (Humedix)
  • Daewoong
  • Croma-Pharma
  • Cleviel (Pharma Research Products)
  • CG Bio
  • Caregen
  • Bohus BioTech
  • Bloomage Bio
  • Beijing IMEIK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Injectable Hyaluronic Acid and Botulinum Toxin Market by Type
  6. 1.3.1 Injectable Hyaluronic Acid
  7. 1.3.2 Botulinum Toxin
  8. 1.4 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Type
  9. 1.4.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Injectable Hyaluronic Acid and Botulinum Toxin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Injectable Hyaluronic Acid and Botulinum Toxin Industry Trends
  2. 2.2 Injectable Hyaluronic Acid and Botulinum Toxin Industry Drivers
  3. 2.3 Injectable Hyaluronic Acid and Botulinum Toxin Industry Opportunities and Challenges
  4. 2.4 Injectable Hyaluronic Acid and Botulinum Toxin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Injectable Hyaluronic Acid and Botulinum Toxin Revenue (2021-2026)
  2. 3.2 Global Top Players by Injectable Hyaluronic Acid and Botulinum Toxin Sales (2021-2026)
  3. 3.3 Global Top Players by Injectable Hyaluronic Acid and Botulinum Toxin Price (2021-2026)
  4. 3.4 Global Injectable Hyaluronic Acid and Botulinum Toxin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Injectable Hyaluronic Acid and Botulinum Toxin Major Company Production Sites & Headquarters
  6. 3.6 Global Injectable Hyaluronic Acid and Botulinum Toxin Company, Product Type & Application
  7. 3.7 Global Injectable Hyaluronic Acid and Botulinum Toxin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Injectable Hyaluronic Acid and Botulinum Toxin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Injectable Hyaluronic Acid and Botulinum Toxin Tier 1, Tier 2, and Tier 3
4 Injectable Hyaluronic Acid and Botulinum Toxin Regional Status and Outlook
  1. 4.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Historic Market Size by Region
  3. 4.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Forecasted Market Size by Region
  7. 4.3.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Injectable Hyaluronic Acid and Botulinum Toxin by Application
  1. 5.1 Injectable Hyaluronic Acid and Botulinum Toxin Market by Application
  2. 5.1.1 Cosmetic
  3. 5.1.2 Medical
  4. 5.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Application
  5. 5.2.1 Global Injectable Hyaluronic Acid and Botulinum Toxin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Injectable Hyaluronic Acid and Botulinum Toxin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Injectable Hyaluronic Acid and Botulinum Toxin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Injectable Hyaluronic Acid and Botulinum Toxin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Haohai Biological
  2. 6.1.1 Haohai Biological Company Information
  3. 6.1.2 Haohai Biological Business Overview
  4. 6.1.3 Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Haohai Biological Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  6. 6.1.5 Haohai Biological Recent Developments
  7. 6.2 AbbVie
  8. 6.2.1 AbbVie Company Information
  9. 6.2.2 AbbVie Business Overview
  10. 6.2.3 AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AbbVie Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  12. 6.2.5 AbbVie Recent Developments
  13. 6.3 US World Meds
  14. 6.3.1 US World Meds Company Information
  15. 6.3.2 US World Meds Business Overview
  16. 6.3.3 US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 US World Meds Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  18. 6.3.5 US World Meds Recent Developments
  19. 6.4 Teoxane
  20. 6.4.1 Teoxane Company Information
  21. 6.4.2 Teoxane Business Overview
  22. 6.4.3 Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Teoxane Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  24. 6.4.5 Teoxane Recent Developments
  25. 6.5 Suneva Medical
  26. 6.5.1 Suneva Medical Company Information
  27. 6.5.2 Suneva Medical Business Overview
  28. 6.5.3 Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Suneva Medical Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  30. 6.5.5 Suneva Medical Recent Developments
  31. 6.6 Sinclair
  32. 6.6.1 Sinclair Company Information
  33. 6.6.2 Sinclair Business Overview
  34. 6.6.3 Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sinclair Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  36. 6.6.5 Sinclair Recent Developments
  37. 6.7 SciVision Biotech
  38. 6.7.1 SciVision Biotech Company Information
  39. 6.7.2 SciVision Biotech Business Overview
  40. 6.7.3 SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SciVision Biotech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  42. 6.7.5 SciVision Biotech Recent Developments
  43. 6.8 Prollenium
  44. 6.8.1 Prollenium Company Information
  45. 6.8.2 Prollenium Business Overview
  46. 6.8.3 Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Prollenium Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  48. 6.8.5 Prollenium Recent Developments
  49. 6.9 Merz
  50. 6.9.1 Merz Company Information
  51. 6.9.2 Merz Business Overview
  52. 6.9.3 Merz Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merz Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  54. 6.9.5 Merz Recent Developments
  55. 6.10 Medytox
  56. 6.10.1 Medytox Company Information
  57. 6.10.2 Medytox Business Overview
  58. 6.10.3 Medytox Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Medytox Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  60. 6.10.5 Medytox Recent Developments
  61. 6.11 LIBP
  62. 6.11.1 LIBP Company Information
  63. 6.11.2 LIBP Business Overview
  64. 6.11.3 LIBP Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 LIBP Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  66. 6.11.5 LIBP Recent Developments
  67. 6.12 LG Life Sciences
  68. 6.12.1 LG Life Sciences Company Information
  69. 6.12.2 LG Life Sciences Business Overview
  70. 6.12.3 LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 LG Life Sciences Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  72. 6.12.5 LG Life Sciences Recent Developments
  73. 6.13 JETEMA
  74. 6.13.1 JETEMA Company Information
  75. 6.13.2 JETEMA Business Overview
  76. 6.13.3 JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 JETEMA Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  78. 6.13.5 JETEMA Recent Developments
  79. 6.14 Ipsen
  80. 6.14.1 Ipsen Company Information
  81. 6.14.2 Ipsen Business Overview
  82. 6.14.3 Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Ipsen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  84. 6.14.5 Ipsen Recent Developments
  85. 6.15 Hugel
  86. 6.15.1 Hugel Company Information
  87. 6.15.2 Hugel Business Overview
  88. 6.15.3 Hugel Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Hugel Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  90. 6.15.5 Hugel Recent Developments
  91. 6.16 Galderma
  92. 6.16.1 Galderma Company Information
  93. 6.16.2 Galderma Business Overview
  94. 6.16.3 Galderma Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Galderma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  96. 6.16.5 Galderma Recent Developments
  97. 6.17 Elravie (Humedix)
  98. 6.17.1 Elravie (Humedix) Company Information
  99. 6.17.2 Elravie (Humedix) Business Overview
  100. 6.17.3 Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Elravie (Humedix) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  102. 6.17.5 Elravie (Humedix) Recent Developments
  103. 6.18 Daewoong
  104. 6.18.1 Daewoong Company Information
  105. 6.18.2 Daewoong Business Overview
  106. 6.18.3 Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Daewoong Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  108. 6.18.5 Daewoong Recent Developments
  109. 6.19 Croma-Pharma
  110. 6.19.1 Croma-Pharma Company Information
  111. 6.19.2 Croma-Pharma Business Overview
  112. 6.19.3 Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Croma-Pharma Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  114. 6.19.5 Croma-Pharma Recent Developments
  115. 6.20 Cleviel (Pharma Research Products)
  116. 6.20.1 Cleviel (Pharma Research Products) Company Information
  117. 6.20.2 Cleviel (Pharma Research Products) Business Overview
  118. 6.20.3 Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Cleviel (Pharma Research Products) Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  120. 6.20.5 Cleviel (Pharma Research Products) Recent Developments
  121. 6.21 CG Bio
  122. 6.21.1 CG Bio Company Information
  123. 6.21.2 CG Bio Business Overview
  124. 6.21.3 CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 CG Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  126. 6.21.5 CG Bio Recent Developments
  127. 6.22 Caregen
  128. 6.22.1 Caregen Company Information
  129. 6.22.2 Caregen Business Overview
  130. 6.22.3 Caregen Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Caregen Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  132. 6.22.5 Caregen Recent Developments
  133. 6.23 Bohus BioTech
  134. 6.23.1 Bohus BioTech Company Information
  135. 6.23.2 Bohus BioTech Business Overview
  136. 6.23.3 Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Bohus BioTech Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  138. 6.23.5 Bohus BioTech Recent Developments
  139. 6.24 Bloomage Bio
  140. 6.24.1 Bloomage Bio Company Information
  141. 6.24.2 Bloomage Bio Business Overview
  142. 6.24.3 Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Bloomage Bio Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  144. 6.24.5 Bloomage Bio Recent Developments
  145. 6.25 Beijing IMEIK
  146. 6.25.1 Beijing IMEIK Company Information
  147. 6.25.2 Beijing IMEIK Business Overview
  148. 6.25.3 Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Beijing IMEIK Injectable Hyaluronic Acid and Botulinum Toxin Product Portfolio
  150. 6.25.5 Beijing IMEIK Recent Developments
7 North America by Country
  1. 7.1 North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country
  2. 7.1.1 North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026)
  4. 7.1.3 North America Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country
  6. 7.2.1 North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country (2021-2026)
  8. 7.2.3 North America Injectable Hyaluronic Acid and Botulinum Toxin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country
  2. 8.1.1 Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026)
  4. 8.1.3 Europe Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country
  6. 8.2.1 Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Injectable Hyaluronic Acid and Botulinum Toxin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country
  2. 9.1.1 Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country
  6. 9.2.1 Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Injectable Hyaluronic Acid and Botulinum Toxin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country
  2. 10.1.1 South America Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026)
  4. 10.1.3 South America Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country
  6. 10.2.1 South America Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country (2021-2026)
  8. 10.2.3 South America Injectable Hyaluronic Acid and Botulinum Toxin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country
  2. 11.1.1 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country
  6. 11.2.1 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Injectable Hyaluronic Acid and Botulinum Toxin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Injectable Hyaluronic Acid and Botulinum Toxin Value Chain Analysis
  2. 12.1.1 Injectable Hyaluronic Acid and Botulinum Toxin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Injectable Hyaluronic Acid and Botulinum Toxin Production Mode & Process
  7. 12.2 Injectable Hyaluronic Acid and Botulinum Toxin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Injectable Hyaluronic Acid and Botulinum Toxin Distributors
  10. 12.2.3 Injectable Hyaluronic Acid and Botulinum Toxin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst